| 发明名称 |
INTRANASAL FORMULATION OF ROTIGOTINE |
| 摘要 |
<p>This invention pertains to a liquid intranasal pharmaceutical formulation comprising a pharmaceutically acceptable acid addition salt of rotigotine and alpha-cyclodextrin, preferably in the form of a buffered aqueous solution having a viscosity of 0.5 - 1.5 mm<2>/s</p> |
| 申请公布号 |
WO2005063236(A1) |
申请公布日期 |
2005.07.14 |
| 申请号 |
WO2004EP14626 |
申请日期 |
2004.12.22 |
| 申请人 |
SCHWARZ PHARMA AG;KRAEMER, ROBERT |
发明人 |
KRAEMER, ROBERT |
| 分类号 |
A61K31/381;A61P25/16;(IPC1-7):A61K31/381 |
主分类号 |
A61K31/381 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
